Report cover image

Global Blue Biotechnology Market Size Study, by Product (Enzymes, Pharma Products, Bulk Chemicals, Biopolymers, Others), by Type (Bioengineering, Genomics, Vaccine Development, Drug Discovery, Fisheries, Aquaculture, Biofuels, Water Treatment Services, Ot

Publisher Factview Research
Published Jul 03, 2025
Length 285 Pages
SKU # FAVR20379127

Description

Global Blue Biotechnology Market was valued at approximately USD 5.49 billion in 2024 and is projected to experience a robust compound annual growth rate (CAGR) of 7.4% over the forecast period from 2024 to 2034. Blue biotechnology involves the application of biotechnology in marine environments, utilizing marine organisms and their biological processes to create innovative products and solutions for various sectors, including healthcare, aquaculture, and environmental management. The increasing demand for marine-derived drugs, coupled with advancements in marine biotechnology research, is propelling market growth.

The Global Blue Biotechnology Market is driven by increasing demand for novel bioactive compounds, growing environmental awareness, and advancements in marine biotechnological research. Moreover, significant opportunities lie in the rising demand for sustainable aquaculture, innovative marine-based pharmaceuticals, and biofuel production. Strategic collaborations and technological innovations are expected to further propel market growth, offering new avenues for exploration and commercial exploitation. However, the high costs associated with research and development, combined with regulatory hurdles and the inherent complexity of marine ecosystems, pose significant challenges to market expansion.

Geographically, North America holds a dominant position in the blue biotechnology market, attributed to its advanced research infrastructure, the presence of key industry players, and substantial investments in marine biotechnology. Furthermore, the Asia-Pacific region is poised for rapid growth, driven by increasing investments in biotechnology, a focus on sustainable aquaculture, and the rich marine biodiversity in nations such as Japan, China, and India.

Major market players included in this report are:

Marshall Marine Products

Marinova

Cyanotech Corporation

ADM

Geomarine

CP Kelco U.S., Inc.

TerSera Therapeutics LLC

Marinomed Biotech AG

Aker BioMarine

Pharma Mar

The detailed segments and sub-segments of the market are explained below:

By Product:
  • Enzymes
  • Pharma Products
  • Bulk Chemicals
  • Biopolymers
  • Others
By Type:
  • Bioengineering
  • Genomics
  • Vaccine Development
  • Drug Discovery
  • Fisheries
  • Aquaculture
  • Biofuels
  • Water Treatment Services
  • Others
By End User:
  • Hospitals
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Others
By Region:

North America
  • U.S.
  • Canada
Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
Latin America
  • Brazil
  • Mexico
  • RoLA
Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA
Years considered for the study are as follows:
  • Historical year – 2022
  • Base year – 2024
  • Forecast period – 2024 to 2034
Key Takeaways:
  • Market Estimates & Forecast for 10 years from 2022 to 2034.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

285 Pages
Chapter 1. Global Blue Biotechnology Market Executive Summary
1.1. Global Blue Biotechnology Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Type
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6 Investment Analysis
1.7 Investment Rationale
1.8 Key Industry Metrics
1.9. Analyst Recommendation & Conclusion
Chapter 2. Global Blue Biotechnology Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Blue Biotechnology Market Dynamics
3.1. Market Drivers
3.1.1. Increasing demand for marine-derived drugs and nutraceuticals
3.1.2. Advancements in marine biotechnology research
3.1.3. Growing focus on sustainable aquaculture practices
3.2. Market Challenges
3.2.1. High research and development costs
3.2.2. Regulatory hurdles
3.2.3. Complexity of marine ecosystems
3.3. Market Opportunities
3.3.1. Expansion of marine bioproduct applications in cosmetics, biofuels, and environmental remediation
3.3.2. Increased investments in marine biotechnology research and infrastructure
Chapter 4. Global Blue Biotechnology Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Blue Biotechnology Market Size & Forecasts by Product 2024-2034
5.1. Segment Dashboard
5.2. Global Blue Biotechnology Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Enzymes
5.2.2. Pharma Products
5.2.3. Bulk Chemicals
5.2.4. Biopolymers
5.2.5. Others
Chapter 6. Global Blue Biotechnology Market Size & Forecasts by Type 2024-2034
6.1. Segment Dashboard
6.2. Global Blue Biotechnology Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Bioengineering
6.2.2. Genomics
6.2.3. Vaccine Development
6.2.4. Drug Discovery
6.2.5. Fisheries
6.2.6. Aquaculture
6.2.7. Biofuels
6.2.8. Water Treatment Services
6.2.9. Others
Chapter 7. Global Blue Biotechnology Market Size & Forecasts by End User 2024-2034
7.1. Segment Dashboard
7.2. Global Blue Biotechnology Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospitals
7.2.2. Pharmaceutical Companies
7.2.3. Biotechnology Companies
7.2.4. Others
Chapter 8. Global Blue Biotechnology Market Size & Forecasts by Region 2024-2034
8.1. North America Blue Biotechnology Market
8.1.1. U.S. Blue Biotechnology Market
8.1.1.1. Product breakdown size & forecasts, 2024-2034
8.1.1.2. Type breakdown size & forecasts, 2024-2034
8.1.1.3. End User breakdown size & forecasts, 2024-2034
8.1.2. Canada Blue Biotechnology Market
8.2. Europe Blue Biotechnology Market
8.2.1. UK Blue Biotechnology Market
8.2.2. Germany Blue Biotechnology Market
8.2.3. France Blue Biotechnology Market
8.2.4. Spain Blue Biotechnology Market
8.2.5. Italy Blue Biotechnology Market
8.2.6. Rest of Europe Blue Biotechnology Market
8.3. Asia-Pacific Blue Biotechnology Market
8.3.1. China Blue Biotechnology Market
8.3.2. India Blue Biotechnology Market
8.3.3. Japan Blue Biotechnology Market
8.3.4. Australia Blue Biotechnology Market
8.3.5. South Korea Blue Biotechnology Market
8.3.6. Rest of Asia Pacific Blue Biotechnology Market
8.4. Latin America Blue Biotechnology Market
8.4.1. Brazil Blue Biotechnology Market
8.4.2. Mexico Blue Biotechnology Market
8.4.3. Rest of Latin America Blue Biotechnology Market
8.5. Middle East & Africa Blue Biotechnology Market
8.5.1. Saudi Arabia Blue Biotechnology Market
8.5.2. South Africa Blue Biotechnology Market
8.5.3. Rest of Middle East & Africa Blue Biotechnology Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Marshall Marine Products
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Marinova
9.3.3. Cyanotech Corporation
9.3.4. ADM
9.3.5. Geomarine
9.3.6. CP Kelco U.S., Inc.
9.3.7. TerSera Therapeutics LLC
9.3.8. Marinomed Biotech AG
9.3.9. Aker BioMarine
9.3.10. Pharma Mar
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us